N-Acetyl-L-cysteine-D3

N-Acetyl-L-cysteine-D3 (NAC-D3) is a derivative of the amino acid L-cysteine that has been modified to include three deuterium atoms. The deuterium atoms replace three of the hydrogen atoms in the molecule, resulting in an isotopically labeled form of N-acetyl-L-cysteine. This modification allows for more accurate and precise analysis of NAC in biological samples. NAC-D3 is commonly used in research studies to investigate the metabolism, pharmacokinetics, and pharmacodynamics of NAC. It can be administered to subjects or added to cell cultures to track the uptake, distribution, and elimination of NAC in the body. By using isotopically labeled compounds, researchers can more accurately measure the concentration and movement of NAC in biological systems. In addition to its research applications, NAC-D3 is also used in clinical settings as a therapeutic agent. NAC has been shown to have antioxidant, anti-inflammatory, and anti-apoptotic properties, making it a promising treatment for a variety of conditions. It is commonly used to treat acetaminophen overdose, as well as chronic obstructive pulmonary disease (COPD), cystic fibrosis, and other respiratory disorders. Overall, N-Acetyl-L-cysteine-D3 is a valuable tool for researchers and clinicians alike, providing insight into the metabolism and therapeutic potential of NAC.